tradingkey.logo
搜索

Protagonist Therapeutics Inc

PTGX
添加自选
112.740USD
+1.300+1.17%
收盘 06/18, 16:00美东报价延迟15分钟
7.06B总市值
亏损市盈率 TTM

机构认同度

单位: USD 更新时间: 2026-06-17
上期评分
10.00
评分变化
0
Protagonist Therapeutics Inc机构持股评分当前评分10.00分,在生物技术与医疗研究行业排名1/388位。 机构最新持股占比118.60%,环比上季度下降0.99%。 机构持股中持股最多的是ETHSX,持股总股数223.17K,占比0.34%,新增持股3369.39%。

机构持股

股东持股明细

名称
持股数
变动比例
BlackRock Institutional Trust Company, N.A.
8.32M
+3.74%
Farallon Capital Management, L.L.C.
6.14M
-0.84%
UBS Financial Services, Inc.
2.77M
+46.12%
RTW Investments L.P.
5.06M
-12.11%
Wellington Management Company, LLP
3.17M
+66.18%
State Street Investment Management (US)
3.20M
+1.07%
Janus Henderson Investors
2.65M
+140.73%
Johnson & Johnson Innovation-JJDC, Inc.
2.45M
--
Geode Capital Management, L.L.C.
1.45M
+2.56%
1
2
KeyAI